Panacea Biotec shares in focus

Why Panacea Biotec shares were locked in 5% upper circuit on Thursday?
As per the company's filing, the United Nations International Children's Emergency Fund (UNICEF) awarded the company to supply 115 million doses of bivalent oral polio vaccine (bOPV) in Africa/Asia
Panacea Biotec shares in focus as co gets UNICEF supply order worth Rs 127 crore
Shares of Panacea Biotec rose 4.99% on Thursday to the day's high of Rs 456 after the company received a Letter of Award from UNICEF for the supply of a polio vaccine worth approximately US$ 14.95 million (Rs 127 crore) in CY2025.
Upper Circuit Stocks: Panacea Biotec shares up 5% post ₹127 crore UNICEF order
Shares of Panacea Biotec are now locked in an upper circuit of 5% at ₹454.90. With today's surge, the stock has rallied over 160% so far in 2024. Over the last 12 months, the stock is up 163%.
Multibagger small-cap stock hits 5% upper circuit on order win from UNICEF. Do you own?
Following a UNICEF order worth ₹127 crore, Panacea Biotec shares increased 5% to ₹456.25. The stock has seen substantial growth in recent times, up 225% over the last six months and 167 per cent year-to-date (YTD).
Panacea Biotec shares in focus on contract from UNICEF
The share touched a 52-week high of Rs 489.00 and a 52-week low of Rs 112.70 on 12 December, 2024 and 04 June, 2024, respectively. Currently, the stock is trading 11.13 percent below its 52-week high and 285.
Panacea Biotec gets UNICEF order to supply 115 mn oral polio vaccines in 2025
Panacea Biotec announced that it was awarded a contract from United Nations International Children's Emergency Fund (UNICEF) to supply 115 million doses of its bivalent oral polio vaccine (bOPV) worth ₹127 crore.
India Infoline1d
Panacea Biotec Wins ₹127 Crore UNICEF Deal to Supply Polio Vaccines
Such a contract symbolizes Panacea Biotec's continued commitment toward global health by contributing its share of the fight ...
Panacea Biotec announces investment in Panacea Biotec Inc.
Panacea Biotec Inc. being a step-down subsidiary of the company. The investment made by PBPL in WOS is to facilitate the capex and working capital requirements of PB Inc. and is in furtherance of its ...
moneycontrol.com3d
Stocks to Watch Today: NALCO, BPCL, Gland Pharma, Panacea Biotec, Ramky Infra, Ceigall India, Manorama in focus on 26 December
NALCO has signed a mining lease deed with the District Collector, Angul, for the amalgamated Utkal-D and Utkal-E coal blocks.
Equity Bulls3d
Panacea Biotec receives LoA from UNICEF for supply of 115 million doses of bOPV
Panacea Biotec Limited has received a Letter of Award from UNICEF for supply of 115 million doses of its bivalent oral polio vaccine (bOPV) worth ~US$ 14.95 million (~Rs.127 Crore) in CY2025.